Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation.
Friebel J, Moritz E, Witkowski M, Jakobs K, Strässler E, Dörner A, Steffens D, Puccini M, Lammel S, Glauben R, Nowak F, Kränkel N, Haghikia A, Moos V, Schutheiss HP, Felix SB, Landmesser U, Rauch BH, Rauch U.
Friebel J, et al. Among authors: dorner a.
Cells. 2021 Dec 13;10(12):3517. doi: 10.3390/cells10123517.
Cells. 2021.
PMID: 34944024
Free PMC article.